adenine has been researched along with Intertrochanteric Fractures in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Whereas tenofovir (TDF) exposure has been associated with decreased bone density, it remains unclear whether it is associated with increased risk of osteoporotic fractures." | 3.78 | Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. ( Bedimo, R; Drechsler, H; Maalouf, NM; Tebas, P; Zhang, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rebolledo, BJ | 1 |
| Unnanuntana, A | 1 |
| Lane, JM | 1 |
| Bedimo, R | 1 |
| Maalouf, NM | 1 |
| Zhang, S | 1 |
| Drechsler, H | 1 |
| Tebas, P | 1 |
2 other studies available for adenine and Intertrochanteric Fractures
| Article | Year |
|---|---|
Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
Topics: Accidental Falls; Adenine; Alendronate; Anti-HIV Agents; Bone Density Conservation Agents; Comorbidi | 2011 |
Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Hi | 2012 |